Your browser doesn't support javascript.
loading
Sorafenib-based therapy in HER2-negative advanced breast cancer: Results from a retrospective pooled analysis of randomized controlled trials.
Tan, Qi-Xing; Qin, Qing-Hong; Lian, Bin; Yang, Wei-Ping; Wei, Chang-Yuan.
Affiliation
  • Tan QX; Breast Surgery Department, Tumor Hospital, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
  • Qin QH; Breast Surgery Department, Tumor Hospital, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
  • Lian B; Breast Surgery Department, Tumor Hospital, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
  • Yang WP; Breast Surgery Department, Tumor Hospital, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
  • Wei CY; Breast Surgery Department, Tumor Hospital, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Exp Ther Med ; 7(5): 1420-1426, 2014 May.
Article in En | MEDLINE | ID: mdl-24940450

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Exp Ther Med Year: 2014 Document type: Article Country of publication: Grecia

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Exp Ther Med Year: 2014 Document type: Article Country of publication: Grecia